Literature DB >> 12030326

Molecular cell biology of Charcot-Marie-Tooth disease.

Philipp Berger1, Peter Young, Ueli Suter.   

Abstract

Charcot-Marie-Tooth disease (CMT), also named hereditary motor and sensory neuropathies, includes a clinically and genetically heterogeneous group of disorders affecting the peripheral nervous system. Traditionally, the different classes of CMT have been divided into demyelinating forms (CMT1, CMT3, and CMT4) and axonal forms (CMT2), a clinically very useful distinction. However, investigations of the underlying molecular and cellular disease mechanisms, mainly accomplished using cell culture and animal models, as well as specific re-examination of appropriate patient cohorts, have revealed that the pathological signs of myelinopathies and axonopathies are often intermingled. These findings, although only recently fully appreciated, are not surprising given the dependence and intimate cellular interactions of Schwann cells and neurons, mainly during nerve development and, as indicated by the pathology of CMT, also in the adult organism. This review is intended to summarize our current knowledge about the molecular and cellular basis of CMT, with a particular emphasis on the role of Schwann cell/axon interactions. Such a view is particularly timely since approximately ten genes have now been identified as culprits in different forms of CMT. This collection revealed novel crucial players in the interplay between Schwann cells and neurons. The analysis of these genes and their encoded proteins will provide additional insights into the molecular and cellular basis of neuropathies and valuable information about the biology and interactions of Schwann cells, their associated neurons, endoneurial fibroblasts, and the nerve-surrounding and protecting perineurial sheath.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12030326     DOI: 10.1007/s10048-002-0130-z

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  28 in total

Review 1.  Myelin P0: new knowledge and new roles.

Authors:  Joseph Eichberg
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

2.  Proteomics of bovine myelin sheath: characterization of a truncated form of P0 by MALDI-TOF/TOF mass spectrometry.

Authors:  Antonio Qualtieri; Elena Urso; Maria Le Pera; Massimo Scornaienchi; Aldo Quattrone; Leonardo Di Donna; Anna Napoli; Giovanni Sindona
Journal:  J Am Soc Mass Spectrom       Date:  2006-01-10       Impact factor: 3.109

3.  Locus-wide identification of Egr2/Krox20 regulatory targets in myelin genes.

Authors:  Sung-Wook Jang; Rajini Srinivasan; Erin A Jones; Guannan Sun; Sunduz Keles; Courtney Krueger; Li-Wei Chang; Rakesh Nagarajan; John Svaren
Journal:  J Neurochem       Date:  2010-11-04       Impact factor: 5.372

4.  Altered axonal mitochondrial transport in the pathogenesis of Charcot-Marie-Tooth disease from mitofusin 2 mutations.

Authors:  Robert H Baloh; Robert E Schmidt; Alan Pestronk; Jeffrey Milbrandt
Journal:  J Neurosci       Date:  2007-01-10       Impact factor: 6.167

5.  Ndrg1-deficient mice exhibit a progressive demyelinating disorder of peripheral nerves.

Authors:  Tomohiko Okuda; Yujiro Higashi; Koichi Kokame; Chihiro Tanaka; Hisato Kondoh; Toshiyuki Miyata
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

6.  Identification of the variant Ala335Val of MED25 as responsible for CMT2B2: molecular data, functional studies of the SH3 recognition motif and correlation between wild-type MED25 and PMP22 RNA levels in CMT1A animal models.

Authors:  Alejandro Leal; Kathrin Huehne; Finn Bauer; Heinrich Sticht; Philipp Berger; Ueli Suter; Bernal Morera; Gerardo Del Valle; James R Lupski; Arif Ekici; Francesca Pasutto; Sabine Endele; Ramiro Barrantes; Corinna Berghoff; Martin Berghoff; Bernhard Neundörfer; Dieter Heuss; Thomas Dorn; Peter Young; Lisa Santolin; Thomas Uhlmann; Michael Meisterernst; Michael Werner Sereda; Michael Sereda; Ruth Martha Stassart; Gerd Meyer zu Horste; Klaus-Armin Nave; André Reis; Bernd Rautenstrauss
Journal:  Neurogenetics       Date:  2009-03-17       Impact factor: 2.660

7.  Charcot-Marie-Tooth disease: a novel Tyr145Ser mutation in the myelin protein zero (MPZ, P0) gene causes different phenotypes in homozygous and heterozygous carriers within one family.

Authors:  Alejandro Leal; Corinna Berghoff; Martin Berghoff; Gerardo Del Valle; Carlos Contreras; Olga Montoya; Erick Hernández; Ramiro Barrantes; Ursula Schlötzer-Schrehardt; Bernhard Neundörfer; André Reis; Bernd Rautenstrauss; Dieter Heuss
Journal:  Neurogenetics       Date:  2003-07-05       Impact factor: 2.660

8.  The tetraspan protein EMP2 modulates the surface expression of caveolins and glycosylphosphatidyl inositol-linked proteins.

Authors:  Madhuri Wadehra; Lee Goodglick; Jonathan Braun
Journal:  Mol Biol Cell       Date:  2004-02-20       Impact factor: 4.138

9.  Charcot-marie-tooth disease: seventeen causative genes.

Authors:  Jung-Hwa Lee; Byung-Ok Choi
Journal:  J Clin Neurol       Date:  2006-06-20       Impact factor: 3.077

10.  Mitochondrial complex I deficiency in GDAP1-related autosomal dominant Charcot-Marie-Tooth disease (CMT2K).

Authors:  Julien Cassereau; Arnaud Chevrollier; Naïg Gueguen; Marie-Claire Malinge; Franck Letournel; Guillaume Nicolas; Laurence Richard; Marc Ferre; Christophe Verny; Frédéric Dubas; Vincent Procaccio; Patrizia Amati-Bonneau; Dominique Bonneau; Pascal Reynier
Journal:  Neurogenetics       Date:  2008-12-17       Impact factor: 2.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.